Euclid Advisors’s Labcorp LH Stock Holding History

Euclid Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,735	Closed	-$306K	–	269
2016 Q2	$306K	Buy	+2,735	New	+$294K	0.01%	417
2016 Q1	–	Sell	-32,022	Closed	-$3.4M	–	486
2015 Q4	$3.4M	Buy	+32,022	New	+$3.3M	0.1%	222
2015 Q3	–	Sell	-5,066	Closed	-$528K	–	347
2015 Q2	$528K	Sell	5,066 -37,513	-88%	-$3.9M	0.01%	394
2015 Q1	$4.61M	Buy	+42,579	New	+$4.38M	0.08%	212
2014 Q4	–	Sell	-50,878	Closed	-$4.45M	–	443
2014 Q3	$4.45M	Buy	50,878 +4,283	+9%	+$387K	0.03%	387
2014 Q2	$4.1M	Sell	46,595 -8,659	-16%	-$750K	0.03%	395
2014 Q1	$4.66M	Buy	55,254 +14,643	+36%	+$1.17M	0.04%	325
2013 Q4	$3.19M	Sell	40,611 -3,573	-8%	-$305K	0.03%	444
2013 Q3	$3.76M	Buy	44,184 +8,053	+22%	+$678K	0.04%	372
2013 Q2	$3.11M	Buy	+36,131	New	+$3M	0.04%	388

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Euclid Advisors's LH Position: Q3 2016 in Review

Euclid Advisors sold out of Labcorp (LH) in Q3 2016, closing a stake of 2,735 shares — an estimated $306K sold.

Euclid Advisors first reported a position in LH in Q2 2013 and held it in 10 quarters. The position peaked at $4.66M in Q1 2014. 673 funds tracked by Wall St. Rank hold LH as of Q3 2016.

Euclid Advisors reported no remaining Labcorp position as of Q3 2016 after selling out during the quarter.
Euclid Advisors sold 2,735 Labcorp shares in Q3 2016, an estimated $306K.
Euclid Advisors first reported a position in Labcorp in Q2 2013 and held it in 10 quarters.
Euclid Advisors's Labcorp position peaked at $4.66M in Q1 2014.
673 funds tracked by Wall St. Rank held Labcorp as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.